Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
48,689,873
-
Shares change
-
-357,840
-
Total reported value, excl. options
-
$292,366,107
-
Value change
-
-$4,019,351
-
Put/Call ratio
-
42.27%
-
Number of buys
-
71
-
Number of sells
-
-55
-
Price
-
$6.05
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q1 2016
172 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q1 2016.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48,689,873 shares
of 294,683,714 outstanding shares and own 16.52% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS INC (6,953,753 shares), BAKER BROS. ADVISORS LP (4,055,876 shares), Bank of New York Mellon Corp (3,359,331 shares), FMR LLC (3,029,683 shares), BlackRock Fund Advisors (2,568,344 shares), VANGUARD GROUP INC (2,460,107 shares), STATE STREET CORP (2,251,763 shares), RA CAPITAL MANAGEMENT, LLC (2,212,036 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,850,000 shares), and BlackRock Institutional Trust Company, N.A. (1,772,275 shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.